186 related articles for article (PubMed ID: 11317521)
1. Establishment and characterization of a new human prostatic cancer cell line: DuCaP.
Lee YG; Korenchuk S; Lehr J; Whitney S; Vessela R; Pienta KJ
In Vivo; 2001; 15(2):157-62. PubMed ID: 11317521
[TBL] [Abstract][Full Text] [Related]
2. VCaP, a cell-based model system of human prostate cancer.
Korenchuk S; Lehr JE; MClean L; Lee YG; Whitney S; Vessella R; Lin DL; Pienta KJ
In Vivo; 2001; 15(2):163-8. PubMed ID: 11317522
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a human primary prostate carcinoma cell line, HH870.
Selvan SR; Cornforth AN; Rao NP; Reid YA; Schiltz PM; Liao RP; Price DT; Heinemann FS; Dillman RO
Prostate; 2005 Apr; 63(1):91-103. PubMed ID: 15468172
[TBL] [Abstract][Full Text] [Related]
4. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
[TBL] [Abstract][Full Text] [Related]
5. Establishment of two human prostate cancer cell lines derived from a single bone metastasis.
Navone NM; Olive M; Ozen M; Davis R; Troncoso P; Tu SM; Johnston D; Pollack A; Pathak S; von Eschenbach AC; Logothetis CJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2493-500. PubMed ID: 9815652
[TBL] [Abstract][Full Text] [Related]
6. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
7. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
[TBL] [Abstract][Full Text] [Related]
8. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
11. A novel human cell culture model for the study of familial prostate cancer.
Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
[TBL] [Abstract][Full Text] [Related]
12. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
Ellis WJ; Vessella RL; Buhler KR; Bladou F; True LD; Bigler SA; Curtis D; Lange PH
Clin Cancer Res; 1996 Jun; 2(6):1039-48. PubMed ID: 9816265
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
[TBL] [Abstract][Full Text] [Related]
16. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
17. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
18. BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis.
McCulloch DR; Opeskin K; Thompson EW; Williams ED
Prostate; 2005 Sep; 65(1):35-43. PubMed ID: 15800936
[TBL] [Abstract][Full Text] [Related]
19. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
20. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
